Affilogic
About
Affilogic is a private biotech company specialized in discovering and developing Nanofitins®-based therapeutics, through in house programs or collaborations with worldwide industry leaders in the pharmaceutical sector. Each Nanofitin® is 20 times smaller than an antibody and hyperstable. Nanofitins® are easily combined by simple, rapid and proven methods to design an ideal targeted molecule.
Affilogic is investing internally in 4 programs which leverage the core advantages of the Nanofitins®:
1 – Bus2Brain : Enhanced brain uptake of biologics to reignite CNS therapies
2 – Respitude : Inhaled antiviral Nanofitin® therapeutics against respiratory infections
3 – GI Job : Targeting GI tract diseases by oral administration
4 – ODC : Small size Nanofitin®-Drug-Conjugates against solid tumours with a new therapeutic window
Moreover, with NanoVector, Affilogic is partnering with third parties to deliver their therapeutic compounds to specific cell/organs (ASO, siRNA, nanoparticles, antibodies, enzymes, peptides, CAR-T, AAV...). Such programs illustrate the versatility of our Nanofitins®, designed as API or as vectors for specific transport of therapeutic molecule, systemically administrable but also via oral route for a local effect in the GI tract or via direct pulmonary delivery.
Business Domain / 分野
Business Type / 業種
Disease Area / 疾患領域
Modalities / モダリティ
Technologies / 技術
Additional questions
Researched company/organisation type / マッチングご希望企業・機関のタイプ
Researched disease area / マッチングご希望の疾患領域
Researched Modality / マッチングご希望のモダリティ
Researched Technologies / マッチングご希望の技術